Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 6
Submit an article Journal homepage
2,893
Views
48
CrossRef citations to date
0
Altmetric
Author's View

Personal neoantigen cancer vaccines

The momentum builds

Edward F Fritsch Broad Institute of Harvard and MIT; Cambridge, MA USA; Department of Medical Oncology; Cancer Vaccine Center; Dana-Farber Cancer Institute; Boston, MA USA
,
Nir Hacohen Broad Institute of Harvard and MIT; Cambridge, MA USA; The Division of Allergy, Immunology and Rheumatology; Department of Medicine; Massachusetts General Hospital; Boston, MA USA
&
Catherine J Wu Broad Institute of Harvard and MIT; Cambridge, MA USA; Department of Medical Oncology; Cancer Vaccine Center; Dana-Farber Cancer Institute; Boston, MA USA; Department of Medicine; Brigham and Women’s Hospital; Harvard Medical School; Boston, MA USACorrespondence[email protected]
Article: e29311 | Received 20 May 2014, Accepted 21 May 2014, Published online: 25 Jun 2014

References

  • Heemskerk B, Kvistborg P, Schumacher TN. The cancer antigenome. EMBO J 2013; 32:194 - 203; http://dx.doi.org/10.1038/emboj.2012.333; PMID: 23258224
  • Hacohen N, Fritsch EF, Carter TA, Lander ES, Wu CJ. Getting personal with neoantigen-based therapeutic cancer vaccines. [Cancer Immunology at the Crossroads] Cancer Immunol Res 2013; 1:11 - 5; http://dx.doi.org/10.1158/2326-6066.CIR-13-0022; PMID: 24777245
  • Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med 2013; 19:747 - 52; http://dx.doi.org/10.1038/nm.3161; PMID: 23644516
  • Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M, Twumasi-Boateng K, Watson PH, Holt RA, et al. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res 2014; 20:1125 - 34; http://dx.doi.org/10.1158/1078-0432.CCR-13-2147; PMID: 24323902
  • Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, Wunderlich JR, Mixon A, Farid S, Dudley ME, et al. PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors. J Clin Invest 2014; 124:2246 - 59; http://dx.doi.org/10.1172/JCI73639; PMID: 24667641
  • Tran E, Turcotte S, Gros A, Robbins PF, Lu Y-C, Dudley ME, Wunderlich JR, Somerville RP, Hogan K, Hinrichs CS, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 2014; 344:641 - 5; http://dx.doi.org/10.1126/science.1251102; PMID: 24812403
  • Fritsch EF, Rajasagi M, Ott PA, Brusic V, Hacohen N, Wu CJ. HLA-binding properties of tumor neoepitopes in humans. Cancer Immunology Research 2014.
  • van Rooij N, van Buuren MM, Philips D, Velds A, Toebes M, Heemskerk B, van Dijk LJ, Behjati S, Hilkmann H, El Atmioui D, et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J Clin Oncol 2013; 31:e439 - 42; http://dx.doi.org/10.1200/JCO.2012.47.7521; PMID: 24043743
  • Burkhardt UE, Hainz U, Stevenson K, Goldstein NR, Pasek M, Naito M, Wu D, Ho VT, Alonso A, Hammond NN, et al. Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest 2013; 123:3756 - 65; http://dx.doi.org/10.1172/JCI69098; PMID: 23912587
  • Rajasagi M, Shukla SA, Fritsch EF, Keskin DB, DeLuca D, Carmona E, Zhang W, Sougnez C, Cibulskis K, Sidney J, et al. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. Blood 2014; 124:453 - 62; http://dx.doi.org/10.1182/blood-2014-04-567933; PMID: 24891321
  • Brown SD, Warren RL, Gibb EA, Martin SD, Spinelli JJ, Nelson BH, Holt RA. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res 2014; 24:743 - 50; http://dx.doi.org/10.1101/gr.165985.113; PMID: 24782321

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.